R&D Allocationv1 · 10.09
What does an AI business sell when it helps run a clinical trial? ↗
Who pays for the work of making AI-enabled trials viable, and what do they buy?
SURPASS calls for validation in real trials, with initial public support and a route to continuing operations. Participation does not establish an automatic allocation of drug development or commercial rights.
- Reports and agreements reviewedRecorded
- Further validationUnverified
- Adoption and benefitUnverified
New question opened
Examine continuing operations and payment for AI-enabled trials through the SURPASS solicitation.
NEXT CHECK
Selected teams, trial execution, payment by later sponsors and terms for model and patient-data use.
Evidence: arpa-h.gov ↗everglade.com ↗